
DEEP TRACK CAPITAL, LP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | GERN | 32.51M | $42.91M |
![]() | DVAX | 15.73M | $241.87M |
![]() | IMVT | 11.53M | $293.02M |
![]() | OCUL | 8.07M | $97.97M |
![]() | APLS | 7.75M | $194.68M |
![]() | CNTX | 7.42M | $10.91M |
![]() | CMPS | 7.33M | $50.61M |
![]() | NRIX | 7.04M | $133.48M |
![]() | VSTM | 5.74M | $44.32M |
![]() | CRMD | 5.27M | $61.34M |
![]() | XFOR | 5.01M | $20.05M |
![]() | ATAI | 4.68M | $19.13M |
![]() | MLTX | 4.61M | $60.76M |
![]() | ENGN | 4.38M | $39.53M |
![]() | MAZE | 4.25M | $175.93M |
![]() | GPCR | 4.11M | $285.97M |
![]() | PCVX | 4.00M | $184.56M |
![]() | LBRX | 3.35M | $74.63M |
![]() | CYTK | 3.34M | $212.03M |
![]() | MBX | 3.25M | $102.50M |

Geron Corporation
GERN
Shares Held
32.51M
Value
$42.91M

Dynavax Technologies Corporation
DVAX
Shares Held
15.73M
Value
$241.87M

Immunovant, Inc.
IMVT
Shares Held
11.53M
Value
$293.02M

Ocular Therapeutix, Inc.
OCUL
Shares Held
8.07M
Value
$97.97M

Apellis Pharmaceuticals, Inc.
APLS
Shares Held
7.75M
Value
$194.68M

Context Therapeutics Inc.
CNTX
Shares Held
7.42M
Value
$10.91M

COMPASS Pathways plc
CMPS
Shares Held
7.33M
Value
$50.61M

Nurix Therapeutics, Inc.
NRIX
Shares Held
7.04M
Value
$133.48M

Verastem, Inc.
VSTM
Shares Held
5.74M
Value
$44.32M

CorMedix Inc.
CRMD
Shares Held
5.27M
Value
$61.34M

X4 Pharmaceuticals, Inc.
XFOR
Shares Held
5.01M
Value
$20.05M

Atai Beckley N.V
ATAI
Shares Held
4.68M
Value
$19.13M

MoonLake Immunotherapeutics
MLTX
Shares Held
4.61M
Value
$60.76M

enGene Holdings Inc.
ENGN
Shares Held
4.38M
Value
$39.53M

Maze Therapeutics, Inc.
MAZE
Shares Held
4.25M
Value
$175.93M

Structure Therapeutics Inc.
GPCR
Shares Held
4.11M
Value
$285.97M

Vaxcyte, Inc.
PCVX
Shares Held
4.00M
Value
$184.56M

LB Pharmaceuticals Inc Common Stock
LBRX
Shares Held
3.35M
Value
$74.63M

Cytokinetics, Incorporated
CYTK
Shares Held
3.34M
Value
$212.03M

MBX Biosciences, Inc. Common Stock
MBX
Shares Held
3.25M
Value
$102.50M
